Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPECT Imaging of Brain Tumors Using 99mTc-1-thio-D-glucose
NCT04288518Phase 2Completed
- Sponsor
- Tomsk National Research Medical Centre of the Russian Academy of Sciences
- Start
- Feb 2020
- Primary completion
- Feb 2021
- Countries
- 1
01
Overview
A Phase 2 trial of 99mTc-1-thio-D-glucose in brain tumor, Benign intracranial neoplasm, sponsored by Tomsk National Research Medical Centre of the Russian Academy of Sciences. Started Feb 2020; status: completed.
02
Drugs
99mTc-1-thio-D-glucose
03
Conditions
brain tumorBenign intracranial neoplasm
Beyond the preview
Go deeper on NCT04288518.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04288518.